Rivipansel flunks Phase III sickle cell trial by Anna Smith | Aug 6, 2019 | News | 0 The trial was for patients six and older with the disease who required treatment with IV opioids for occlusive crisis. Read More
Rituxan hits endpoints in late-stage skin disease trial by Anna Smith | Jun 14, 2019 | News | 0 The drug demonstrated superiority to current standard-of-care to CellCept. Read More